Ryan Maynard - Sep 12, 2022 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Role
Chief Financial Officer
Signature
/s/ Darren DeStefano, Attorney-in-Fact
Stock symbol
CARA
Transactions as of
Sep 12, 2022
Transactions value $
$0
Form type
4
Date filed
9/14/2022, 04:42 PM
Previous filing
Jun 14, 2022
Next filing
Mar 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CARA Stock Option (Right to Buy) Award $0 +225K $0.00 225K Sep 12, 2022 Common Stock 225K $10.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares will vest and become exercisable on September 12, 2023 and the remainder will vest over the following 36 equal monthly installments, in each case, subject to the Reporting Person's continued service to the Issuer as of each such date.